Identification and characterization of genes responsive to apoptosis: Application of DNA chip technology and mRNA differential display

Histology and Histopathology

Volumn 15, Issue 4, 2000, Pages 1271-1284

  Sun, Y ^a  

^a PFIZER INC   (United States)

Author keywords

Apoptosis; Cancer; DNA chip technology; DNA damage; GSS; mRNA differential display; Proliferation; Reactive oxygen species; Redox; SAG

Indexed keywords

1,10 PHENANTHROLINE; DNA; ETOPOSIDE; GLUTATHIONE SYNTHASE; MESSENGER RNA; PROTEIN P53;

APOPTOSIS; CANCER; CELL PROLIFERATION; CELL PROTECTION; CLONING; DNA CHIP; DNA DAMAGE; DNA HYBRIDIZATION; DRUG TARGETING; GENE ACTIVATION; GENETIC CODE; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN DEGRADATION; RECOMBINANT DNA TECHNOLOGY; REVIEW; SIGNAL TRANSDUCTION; YEAST;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; DNA; HUMAN; MICROCOMPUTERS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033814485     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Etoposide. Current and future status
2. Death receptors: Signaling and modulation
3. Clinical applications of detecting dysfunctional p53 tumor suppressor protein
4. IkappaB-NF-kappaB structures: At the interface of inflammation control
5. Modulation of life and death by the TNF receptor superfamily
6. Suppression of human colorectal carcinoma cell growth by wild-type p53
7. The NF-kappa B and I kappa B proteins: New discoveries and insights
8. The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death
9. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
10. Etoposide: Current status and future perspectives in the management of malignant neoplasms
11. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter
12. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
13. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
14. A genome-wide transcriptional analysis of the mitotic cell cycle
15. The ubiquitin-proteasome pathway: On protein death and cell life
16. Control of programmed cell death by the baculovirus genes p35 and iap
17. Cell cycle and cancer
18. Proteases to die for
19. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
20. The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin
21. Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays
22. Signal transduction pathways that regulate cell survival and cell death
23. SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents
24. Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but its antisense transfection inhibits tumor cell growth
25. DNA arrays for analysis of gene expression
26. Definition of a consensus binding site for p53
27. WAF1, a potential mediator of p53 tumor suppression
28. Cdk inhibitors: On the threshold of checkpoints and development
29. A matter of life and cell death
30. A license to kill
31. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
32. The complexity of p53 modulation: Emerging patterns from divergent signals
33. Genomic profiling of drug sensitivities via induced haploinsufficiency
34. Differential display analysis of gene expression indicates that age-related changes are restricted to a small cohort of genes
35. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
36. Resequencing and mutational analysis using oligonucleotide microarrays
37. Applications of DNA chips for genomic analysis
38. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
39. Cell cycle control and cancer
40. Programmed cell death in Caenorhabditis elegans
41. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression
42. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
43. Identification of redox/repair protein Ref-1 as a potent activator of p53
44. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
45. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
46. P53, cell cycle control and apoptosis: Implications for cancer
47. Participation of p53 protein in the cellular response to DNA damage
48. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
49. How proteolysis drives the cell cycle
50. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
51. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
52. p53: Puzzle and paradigm
53. The proto-oncogene Bcl-2 and its role in regulating apoptosis
54. The biochemistry of programmed cell death
55. p53 and human cancers
56. Gene expression profile of aging and its retardation by caloric restriction
57. p53, the cellular gatekeeper for growth and division
58. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
59. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
60. Differential display. A general protocol
61. High density synthetic oligonucleotide arrays
62. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
63. Expression monitoring by hybridization to high-density oligonucleotide arrays
64. p53 status and the efficacy of cancer therapy in vivo
65. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
66. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53
67. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless and Hedgehog signaling pathways
68. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis
69. The expression of the KAl1 gene, a tumor metastasis suppressor, is directly activated by p53
70. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
71. Mitochondria and apoptosis
72. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
73. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide
74. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
75. Apoptosis by death factor
76. Caspases: The proteases of the apoptotic pathway
77. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity
78. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
79. Deletion of the Saccharomyces cerevisiae TRR1 gene encoding thioredoxin reductase inhibits p53-dependent reporter gene expression
80. Differential expression of TIMP-3 during neoplastic progression in the mouse JB6 model system
81. Advances in apoptosis research
82. A model for p53-induced apoptosis
83. The anticancer drugs. 2nd Edn
84. DNA chips: State-of-the art
85. Double identity for proteins of the Bcl-2 family
86. Bcl-2 family proteins
87. The ubiquitin-mediated proteolytic pathway as a therapeutic area
88. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway
89. Caspases: Intracellular signaling by proteolysis
90. p53: A cell cycle regulator activated by DNA damage
91. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34
92. G1 phase progression: Cycling on cue
93. Inhibitors of mammalian G1 cyclin-dependent kinases
94. A single mouse glutathione synthetase gene encodes six mRNAs with different 5' ends
95. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
96. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1
97. Mechanisms and genes of cellular suicide
98. Baculovirus p53 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans
99. Free radicals, antioxidant enzymes and carcinogenesis
100. Induction of glutathione synthetase by 1, 10-phenanthroline
101. Alteration of SAG mRNA in human cancer cell lines: Requirement for the RING finger domain for apoptosis protection
102. Redox regulation of transcriptional activators
103. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: One is homologous to human tissue inhibitor of metalloproteinases-3
104. Alterations of the p53 tumor-suppressor gene in transformed mouse liver cells
105. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants
106. Status of the MDM-2 and WAF-1 genes in mouse epidermal JB6 variants harboring wild-type p53: A p53-independent induction of WAF-1
107. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation
108. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness
109. Activation of p53 transcriptional activity by 1, 10-phenanthroline, a metal chelator and redox sensitive compound
110. p53 down-regulates human matrix metalloproteinase-1 (Collagenase-1) gene expression
111. Regulation of metastasis-related gene expression by p53: A potential clinical implication
112. Expression, purification and biochemical characterization of SAG, a RING finger redox sensitive protein
113. Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth, but not for germination: Chip profiling implicates its role in cell cycle regulation
114. Transcriptional activation of the human S100A2 promoter by wildtype p53
115. Transcriptional activation of the human glutathione peroxidase promoter by p53
116. PTGFβ, a type β transforming growth factor (TGFβ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGFβ signaling pathway
117. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IκBα
118. Apoptosis in the pathogenesis and treatment of disease
119. Caspases: Enemies within
120. One ring to rule a superfamily of E3 ubiquitin ligases
121. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells
122. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1
123. Toward an understanding of the molecular mechanisms of physiological cell death
124. An evolutionary perspective on apoptosis
125. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
126. Regulation of p53 by metal ions and by antioxidants: Dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper
127. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc
128. Identification of the genes responsive to etoposide-induced apoptosis: Application of DNA chip technology
129. Genome-wide expression monitoring in Saccharomyces cerevisiae
130. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
131. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
132. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity
133. Cell death: The significance of apoptosis
134. p21 is a universal inhibitor of cyclin kinases
135. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
136. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 (CIP1/WAF1) and cyclin D proteins
137. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
138. p53 regulates the expression of the tumor suppressor gene maspin